Screening Tool for Substance Abuse

(TAPS-ESP Trial)

Overseen By Brittany Meredith, Masters

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Baylor Research Institute

Disqualifiers: Inability to consent, comprehend, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests the TAPS-ESP tool to help doctors in primary care identify and treat substance use issues. The study evaluates the tool's effectiveness when used by patients themselves and by interviewers. It targets individuals who prefer Spanish, are patients at the participating clinic, and can read Spanish. Participants should be comfortable using a tablet to answer questions about substance use. As an unphased trial, this study offers a unique opportunity to contribute to research that could enhance primary care for Spanish-speaking patients.

Do I need to stop my current medications to join the trial?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that this screening tool is safe for use in primary care?

Research shows that the TAPS-ESP tool, which stands for Tobacco, Alcohol, Prescription medication, and illicit Substance use screening, is a two-step process that helps doctors check for substance use. Studies confirm that this tool is user-friendly. Many places have used it to screen for substance use without causing harm. As a questionnaire, the TAPS-ESP does not involve medication or physical tests, ensuring safety. No reports of problems have arisen from its use. By answering questions honestly, the tool can help identify substance use issues early. ^{1 2 3 4 5}

Why are researchers excited about this trial?

Researchers are excited about the TAPS-ESP because it aims to improve how we screen for substance abuse by introducing a bilingual assessment tool. Unlike traditional English-only screening methods, TAPS-ESP is translated into Spanish, making it more accessible to Spanish-speaking individuals. This trial is also comparing two methods of administration — self-administered versus interviewer-administered — to determine which is more effective. By tailoring the tool to a broader audience and exploring the best way to administer it, the trial seeks to refine and enhance substance abuse screening practices.

What evidence suggests that the TAPS-ESP is effective for screening substance use?

Research shows that the TAPS-ESP effectively identifies issues with substance use, such as tobacco, alcohol, prescription drugs, and illegal drugs. Studies have demonstrated its effectiveness in checking and evaluating these issues in two steps. This trial will compare two methods of administering the TAPS-ESP: one group will self-administer the tool followed by an interviewer-administered session, while the other group will experience the reverse order. This tool excels at identifying substance use problems that are often missed. It is a proven method and has been translated into Spanish to reach more people. Early results suggest it could play a crucial role in primary care settings by identifying substance use problems early, helping to prevent serious health issues. ^{1 3 5 6 7}

Who Is on the Research Team?

Katherine Sanchez, PhD

Principal Investigator

Baylor Scott and White Research Institute

Are You a Good Fit for This Trial?

This trial is for Spanish-speaking adults who are current patients at the clinic and can read Spanish. It's designed for those seeking screening and treatment for substance use, including tobacco, alcohol, prescription drugs, or other illicit substances.

Inclusion Criteria

Ability to read Spanish

Current patient of the clinic

I prefer to communicate in Spanish.

Exclusion Criteria

I cannot use an iPad by myself because of physical limitations.

Inability to comprehend or read Spanish

I am unable to understand and give consent for treatment.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Validation

Validation of the TAPS-ESP against established diagnostic and biomarker metrics

1 year

Follow-up

Participants are monitored for safety and effectiveness after validation

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

• TAPS-ESP

Trial Overview The study aims to validate the TAPS-ESP as a tool in primary care settings for identifying and assessing substance use issues. Participants will self-administer this screening tool on an iPad.

How Is the Trial Designed?

Group I: Self-Administration followed by Interviewer-Administered Active Control 1 Intervention

Screening and validation of assessment tool translated into Spanish

Group II: Interviewer-Administered followed by Self-Administration Active Control 1 Intervention

Screening and validation of assessment tool translated into Spanish

Who Is Running the Clinical Trial?

Baylor Research Institute

Lead Sponsor

Trials

210

Recruited

205,000+

COG Analytics

Collaborator

Trials

4

Recruited

1,200+

Citations

1. clinicaltrials.gov clinicaltrials.gov/ct2/show/NCT03879785

TAPS-ESP: Tobacco, Alcohol, Prescription Drug, and Illicit ... Moreover, failure to identify unhealthy alcohol and other drug use can produce harmful medication interactions, resulting in significant clinical complications.

2. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov/articles/PMC10652452/

The Spanish language version of the TAPS tool Drug Abuse Screening Test (DAST-10): The DAST-10 is a ten-item yes/no screen for general drug use problems (not including alcohol). Each item is ...

3. clinicaltrials.gov clinicaltrials.gov/study/NCT05476588

Tobacco, Alcohol, Prescription Drug, and Illicit Substance ... TAPS-ESP is a two-stage screening and assessment tool that first screens for 4 broad substance abuse categories (tobacco, alcohol, prescription drug misuse, and ...

4. researchgate.net researchgate.net/publication/342848093_Development_and_Feasibility_of_a_Spanish_Language_Version_of_the_Tobacco_Alcohol_Prescription_Drug_and_Illicit_Substance_Use_TAPS_Tool

Development and Feasibility of a Spanish Language ... Objectives: The Tobacco, Alcohol, Prescription drug, and illicit Substance use (TAPS) Tool is a validated two-stage screening and brief assessment in ...

5. journals.plos.org journals.plos.org/plosone/article?id=10.1371/journal.pone.0305142

TAPS-tool reveals severe under detection of substance use ... Conclusions. Screening for addiction in an SMI sample with the TAPS-tool revealed a high prevalence of substance use and a high risk of SUD.

6. nida.nih.gov nida.nih.gov/taps2/

TAPS ... Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients. ... logo for National Institute of Drug Abuse logo for USA.gov website.

7. ascpjournal.biomedcentral.com ascpjournal.biomedcentral.com/articles/10.1186/s13722-023-00423-9

The Spanish language version of the TAPS tool: protocol for a ... Drug Abuse Screening Test (DAST-10): The DAST-10 is a ten-item yes/no screen for general drug use problems (not including alcohol). Each item is ...